Psoriasis drugs may weaken defenses against genital warts

NCT ID NCT07234838

First seen Nov 18, 2025 · Last updated May 21, 2026 · Updated 21 times

Summary

This study examines whether biologic drugs for psoriasis (targeting TNF-α, IL-17, or IL-23) increase the chance of developing or recurring genital warts. Researchers will review past medical records and follow 600 adults with moderate-to-severe psoriasis for 24 months. They will also ask about willingness to get the HPV vaccine. The goal is to understand how these immune-modulating treatments affect the body's ability to fight HPV.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSORIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU Brugmann

    RECRUITING

    Brussels, Brussels Capital, 1020, Belgium

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • CHU Saint-Pierre

    RECRUITING

    Brussels, Brussels Capital, 1000, Belgium

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

  • Hôpital Erasme

    RECRUITING

    Brussels, Brussels Capital, 1070, Belgium

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.